EDMONTON, Aug. 11 /CNW/ - (ISA:TSX): Isotechnika Inc. today announced two
principal investigators from the Company's recently completed Phase 2b kidney
transplant (PROMISE) trial have been selected to make oral presentations at
the 22nd International Congress of the Transplantation Society Conference in
Sydney, Australia.
